iSpecimen (ISPC) Capital Expenditures (QoQ) (2020 - 2026)
iSpecimen (ISPC) Capital Expenditures (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | iSpecimen | 658,857.59 | -2.16 Mn | 71,599.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 170.03% |
| Dec 31, 2025 | -200.00% |
| Dec 31, 2024 | 101.85% |
| Sep 30, 2024 | -196.68% |
| Jun 30, 2024 | 4,700.25% |
| Sep 30, 2023 | -327.53% |
| Jun 30, 2023 | -22.58% |
| Mar 31, 2023 | 215.43% |
| Dec 31, 2022 | -272.75% |
| Sep 30, 2022 | 76.27% |
| Jun 30, 2022 | 29.15% |
| Mar 31, 2022 | 146.55% |
| Dec 31, 2021 | -200.00% |
| Sep 30, 2021 | 443.72% |
| Jun 30, 2021 | -198.81% |
| Mar 31, 2021 | 37,088.62% |
| Dec 31, 2020 | 99.90% |